Incidence and risk factors of kidney impairment on patients with COVID-19: A meta-analysis of 10180 patients.

<h4>Background</h4>The novel coronavirus is pandemic around the world. Several researchers have given the evidence of impacts of COVID-19 on the respiratory, cardiovascular and gastrointestinal system. Studies still have debated on kidney injury of COVID-19 patients. The purpose of the m...

Full description

Bibliographic Details
Main Authors: Qixin Yang, Xiyao Yang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0241953
id doaj-32147417178a43a3afe79a14fad404cd
record_format Article
spelling doaj-32147417178a43a3afe79a14fad404cd2021-03-04T11:52:28ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-011511e024195310.1371/journal.pone.0241953Incidence and risk factors of kidney impairment on patients with COVID-19: A meta-analysis of 10180 patients.Qixin YangXiyao Yang<h4>Background</h4>The novel coronavirus is pandemic around the world. Several researchers have given the evidence of impacts of COVID-19 on the respiratory, cardiovascular and gastrointestinal system. Studies still have debated on kidney injury of COVID-19 patients. The purpose of the meta-analysis was to evaluate the association of kidney impairment with the development of COVID-19.<h4>Methods</h4>The PubMed, Embase and MedRxiv databases were searched until May 1, 2020. We extracted data from eligible studies to summarize the clinical manifestations and laboratory indexes of kidney injury on COVID-19 infection patients and further compared the prevalence of acute kidney injury (AKI) and the mean differences of three biomarkers between in ICU/severe and non-ICU/non-severe cases. Heterogeneity was evaluated using the I2 method.<h4>Results</h4>In the sum of 24 studies with 10180 patients were included in this analysis. The pooled prevalence of AKI, increased serum creatinine (Scr), increased blood urea nitrogen (BUN), increased D-dimer, proteinuria and hematuria in patients with COVID-19 were 16.2%, 8.3%, 6.2%, 49.8%, 50.1% and 30.3% respectively. Moreover, the means of Scr, BUN and D-dimer were shown 6.4-folds, 1.8-folds and 0.67-folds, respectively, higher in ICU/severe cases than in corresponding non-ICU/non-severe patients. The prevalence of AKI was about 30 folds higher in ICU/severe patients compared with the non-ICU/non-severe cases.<h4>Conclusions</h4>Overall, we assessed the incidences of the clinic and laboratory features of kidney injury in COVID-19 patients. And kidney dysfunction may be a risk factor for COVID-19 patients developing into the severe condition. In reverse, COVID-19 can also cause damage to the kidney.https://doi.org/10.1371/journal.pone.0241953
collection DOAJ
language English
format Article
sources DOAJ
author Qixin Yang
Xiyao Yang
spellingShingle Qixin Yang
Xiyao Yang
Incidence and risk factors of kidney impairment on patients with COVID-19: A meta-analysis of 10180 patients.
PLoS ONE
author_facet Qixin Yang
Xiyao Yang
author_sort Qixin Yang
title Incidence and risk factors of kidney impairment on patients with COVID-19: A meta-analysis of 10180 patients.
title_short Incidence and risk factors of kidney impairment on patients with COVID-19: A meta-analysis of 10180 patients.
title_full Incidence and risk factors of kidney impairment on patients with COVID-19: A meta-analysis of 10180 patients.
title_fullStr Incidence and risk factors of kidney impairment on patients with COVID-19: A meta-analysis of 10180 patients.
title_full_unstemmed Incidence and risk factors of kidney impairment on patients with COVID-19: A meta-analysis of 10180 patients.
title_sort incidence and risk factors of kidney impairment on patients with covid-19: a meta-analysis of 10180 patients.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2020-01-01
description <h4>Background</h4>The novel coronavirus is pandemic around the world. Several researchers have given the evidence of impacts of COVID-19 on the respiratory, cardiovascular and gastrointestinal system. Studies still have debated on kidney injury of COVID-19 patients. The purpose of the meta-analysis was to evaluate the association of kidney impairment with the development of COVID-19.<h4>Methods</h4>The PubMed, Embase and MedRxiv databases were searched until May 1, 2020. We extracted data from eligible studies to summarize the clinical manifestations and laboratory indexes of kidney injury on COVID-19 infection patients and further compared the prevalence of acute kidney injury (AKI) and the mean differences of three biomarkers between in ICU/severe and non-ICU/non-severe cases. Heterogeneity was evaluated using the I2 method.<h4>Results</h4>In the sum of 24 studies with 10180 patients were included in this analysis. The pooled prevalence of AKI, increased serum creatinine (Scr), increased blood urea nitrogen (BUN), increased D-dimer, proteinuria and hematuria in patients with COVID-19 were 16.2%, 8.3%, 6.2%, 49.8%, 50.1% and 30.3% respectively. Moreover, the means of Scr, BUN and D-dimer were shown 6.4-folds, 1.8-folds and 0.67-folds, respectively, higher in ICU/severe cases than in corresponding non-ICU/non-severe patients. The prevalence of AKI was about 30 folds higher in ICU/severe patients compared with the non-ICU/non-severe cases.<h4>Conclusions</h4>Overall, we assessed the incidences of the clinic and laboratory features of kidney injury in COVID-19 patients. And kidney dysfunction may be a risk factor for COVID-19 patients developing into the severe condition. In reverse, COVID-19 can also cause damage to the kidney.
url https://doi.org/10.1371/journal.pone.0241953
work_keys_str_mv AT qixinyang incidenceandriskfactorsofkidneyimpairmentonpatientswithcovid19ametaanalysisof10180patients
AT xiyaoyang incidenceandriskfactorsofkidneyimpairmentonpatientswithcovid19ametaanalysisof10180patients
_version_ 1714803420918972416